Anti-inflammatory cytokine gene therapy decreases sensory and motor dysfunction in experimental Multiple Sclerosis: MOG-EAE behavioral and anatomical symptom treatment with cytokine gene therapy.

Source:http://linkedlifedata.com/resource/pubmed/id/18835435

Download in:

View as

General Info

PMID
18835435